6.2% Annual Growth For World Pharma Sales

24 July 1997

Worldwide, the pharmaceutical market is forecast to grow at a compoundaverage growth rate of 6.2% a year, to reach $378 billion in 2001 from an estimated value of $297.3 billion in 1997, according to Global Pharma Forecasts 1997-2001 from IMS' Pharma Strategy Group. The report covers 230 countries in 11 regions.

Market growth was a modest 1.6% in 1996, compared with double-digit expansion the previous year, it notes. Major limiting factors in 1996 included low growth in Japan as well as in a number of European markets, and this was compounded by the strength of the US dollar against the yen and major European currencies.

Selected Region Forecasts Region CAGR % CAGR % 1992-96 1997-2001 -------------------------------------- North America 5.7% 6.5% Europe 3.9% 5.7% Japan 11.7% -0.7% Latin America/Carib 14.7% 10.6% SE Asia & China 10.4% 12.3%

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight